fenofibrate has been researched along with Adverse Drug Event in 8 studies
Pharmavit: a polyvitamin product, comprising vitamins A, D2, B1, B2, B6, C, E, nicotinamide, & calcium pantothene; may be a promising agent for application to human populations exposed to carcinogenic and genetic hazards of ionizing radiation; RN from CHEMLINE
| Excerpt | Relevance | Reference |
|---|---|---|
| " We proposed a systematic classification scheme using FDA-approved drug labeling to assess the DILI potential of drugs, which yielded a benchmark dataset with 287 drugs representing a wide range of therapeutic categories and daily dosage amounts." | 1.37 | FDA-approved drug labeling for the study of drug-induced liver injury. ( Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 6 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pedersen, JM | 1 |
| Matsson, P | 1 |
| Bergström, CA | 1 |
| Norinder, U | 1 |
| Hoogstraate, J | 1 |
| Artursson, P | 1 |
| Li, J | 1 |
| Kennedy, LJ | 1 |
| Shi, Y | 1 |
| Tao, S | 1 |
| Ye, XY | 1 |
| Chen, SY | 1 |
| Wang, Y | 1 |
| Hernández, AS | 1 |
| Wang, W | 1 |
| Devasthale, PV | 1 |
| Chen, S | 1 |
| Lai, Z | 1 |
| Zhang, H | 2 |
| Wu, S | 1 |
| Smirk, RA | 1 |
| Bolton, SA | 1 |
| Ryono, DE | 1 |
| Lim, NK | 1 |
| Chen, BC | 1 |
| Locke, KT | 1 |
| O'Malley, KM | 1 |
| Zhang, L | 2 |
| Srivastava, RA | 1 |
| Miao, B | 1 |
| Meyers, DS | 1 |
| Monshizadegan, H | 1 |
| Search, D | 1 |
| Grimm, D | 1 |
| Zhang, R | 1 |
| Harrity, T | 1 |
| Kunselman, LK | 1 |
| Cap, M | 1 |
| Kadiyala, P | 1 |
| Hosagrahara, V | 1 |
| Xu, C | 1 |
| Li, YX | 1 |
| Muckelbauer, JK | 1 |
| Chang, C | 1 |
| An, Y | 1 |
| Krystek, SR | 1 |
| Blanar, MA | 1 |
| Zahler, R | 1 |
| Mukherjee, R | 1 |
| Cheng, PT | 1 |
| Tino, JA | 1 |
| Chen, M | 1 |
| Vijay, V | 1 |
| Shi, Q | 2 |
| Liu, Z | 2 |
| Fang, H | 2 |
| Tong, W | 2 |
| Ding, D | 1 |
| Kelly, R | 1 |
| Sakatis, MZ | 1 |
| Reese, MJ | 1 |
| Harrell, AW | 1 |
| Taylor, MA | 1 |
| Baines, IA | 1 |
| Chen, L | 1 |
| Bloomer, JC | 1 |
| Yang, EY | 1 |
| Ellens, HM | 1 |
| Ambroso, JL | 1 |
| Lovatt, CA | 1 |
| Ayrton, AD | 1 |
| Clarke, SE | 1 |
| Morgan, RE | 1 |
| van Staden, CJ | 1 |
| Chen, Y | 1 |
| Kalyanaraman, N | 1 |
| Kalanzi, J | 1 |
| Dunn, RT | 1 |
| Afshari, CA | 1 |
| Hamadeh, HK | 1 |
| Grandi, AM | 1 |
| Nicolini, E | 1 |
| Rizzi, L | 1 |
| Caputo, S | 1 |
| Annoni, F | 1 |
| Cremona, AM | 1 |
| Marchesi, C | 1 |
| Guasti, L | 1 |
| Maresca, AM | 1 |
| Grossi, P | 1 |
| Vargas, F | 1 |
| Rivas, C | 1 |
| Canudas, N | 1 |
| Torrealba, A | 1 |
| Sarabia, Z | 1 |
1 review available for fenofibrate and Adverse Drug Event
| Article | Year |
|---|---|
[Mechanism of phototoxicity induced by drugs].
Topics: 4-Quinolones; Anti-Infective Agents; Butyrates; Dermatitis, Phototoxic; Drug-Related Side Effects an | 1996 |
1 trial available for fenofibrate and Adverse Drug Event
| Article | Year |
|---|---|
Dyslipidemia in HIV-positive patients: a randomized, controlled, prospective study on ezetimibe+fenofibrate versus pravastatin monotherapy.
Topics: Adult; Anticholesteremic Agents; Azetidines; Drug-Related Side Effects and Adverse Reactions; Dyslip | 2014 |
6 other studies available for fenofibrate and Adverse Drug Event
| Article | Year |
|---|---|
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Bi | 2008 |
Discovery of an oxybenzylglycine based peroxisome proliferator activated receptor alpha selective agonist 2-((3-((2-(4-chlorophenyl)-5-methyloxazol-4-yl)methoxy)benzyl)(methoxycarbonyl)amino)acetic acid (BMS-687453).
Topics: Animals; Cell Line; Cricetinae; Crystallography, X-Ray; Drug Discovery; Drug-Related Side Effects an | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Des | 2011 |
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Chemical and Drug Induced Liver Injury; Da | 2011 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily | 2013 |